|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.6004 - 0.6358|
|52 Week Range||0.3715 - 1.9855|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||2.39|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Three of Canopy Rivers Inc.'s ("Canopy Rivers") (TSX: RIV) (OTC: CNPOF) portfolio companies have made recent announcements as they aim to introduce new or expanded choices for cannabis consumers and medical patients in Canada and the U.S.
Dynaleo Inc. ("Dynaleo"), the most recent addition to Canopy Rivers Inc.'s ("Canopy Rivers") (TSX: RIV) (OTC: CNPOF) portfolio of disruptive cannabis companies, has received its Standard Processing Licence from Health Canada. This follows the completion and commissioning of Dynaleo's 27,000 square foot purpose-built facility, and is a key milestone as it aims to ramp up production of white label gummies for the Canadian recreational market. Dynaleo plans to develop and close on its existing customer pipeline that includes licensed producers and traditional consumer packaged goods companies.
Mr. Lee joins a Board that already has executives drawn from multiple industries, a wealth of strategic industry know-how, and significant public company governance experience. The Company expects that Mr. Lee's experience at Canopy Growth, Constellation Brands, Inc. ("Constellation Brands"), and other leading consumer packaged goods and beverage companies will help strengthen its strategic execution as it continues to focus on developing a leading global cannabis portfolio.